When was Leanbio founded?

Leanbio was founded in 2014 and raised its 1st funding round 7 years after it was founded.

Where is Leanbio located?

Leanbio is headquartered in Barcelona, Spain.

How many employees does Leanbio have?

As of Sep 30, 2026, the latest employee count at Leanbio is 49.

Is Leanbio a funded company?

Leanbio is a funded company, having raised a total of $6.28M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 01, 2021.

When was the latest funding round of Leanbio?

Leanbio's latest funding was a $***** Angel round on Apr 08, 2024, with participation from 0 investor.

Where does Leanbio rank among its competitors?

Leanbio ranks 48th amongst 350 active competitors, of which 22 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Abingdon Health, which secured $4.4M in Oct, 2025.

Who are the top competitors of Leanbio?

Leanbio's top competitors include Anthem Biosciences, Patheon and Aragen. Among them, Abingdon Health secured the most recent funding round in October, 2025.

Leanbio - 2026 Company Profile, Team, Funding & Competitors

Leanbio is an acquired company based in Barcelona (Spain), founded in 2014. It operates as a Manufacturer of biopharmaceutical product in immunotherapy. Leanbio has raised $6.28M in funding. The company has 350 active competitors, including 22 funded and 99 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and Aragen.

Company Details

Manufacturer of biopharmaceutical product in immunotherapy. The company has developed recombinant protein in E. coli, CHO mammalian cell line, P. pastoris and S. cerevisiae. The company has developed a platform for upstream (USP) and downstream (DSP) of microbial and mammalian cell cultures and purification of a biotherapeutics. It also developed a platform for the analysis and formulation of protein therapeutics.

Website: leanbiopro.com
Social
Email ID: *****@leanbiopro.com

Key Metrics

Founded Year

2014

Location

Barcelona, Spain

Stage

Acquired

Total Funding

$6.28M in 2 rounds

Latest Funding Round

Angel, Apr 08, 2024, $*****

Investors

Europa

Ranked

48^th among 350 active competitors

Employee Count

49 as on Sep 30, 2026

Similar Companies

EirGenix & 161 more

Exit Details

Acquired by Laboratorio Reig Jofre (Dec 02, 2025)

View Leanbio's full profile

Leanbio got acquired by Laboratorio Reig Jofre on Dec 02, 2025.

Click here to take a look at Leanbio's acquisition in detail

Leanbio has raised a total funding of $6.28M over 2 rounds. Its first funding round was on Mar 01, 2021. Leanbio has 1 institutional investor.

Here is the list of recent funding rounds of Leanbio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 08, 2024	6835250	Angel	4327377	1158644	2221739	7870856
Mar 01, 2021	8746723	Grant (prize money)	7536270	1309820	7035342	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Leanbio's funding rounds and investors

Leanbio's employee count trend

Leanbio has 49 employees as of Sep 26. Here is Leanbio's employee count trend over the years:

Uncover Leanbio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Leanbio include Anthem Biosciences, Patheon and Aragen. Here is the list of Top 10 competitors of Leanbio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Anthem Biosciences 2006, Bengaluru (India), Public	Developer of integrated contract research development and manufacturing services	$35.7M	Portsmouthtechnologiestrialsunit, True North ... & 8 others	76/100
2nd	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	Frazier Healthcare Partners, Audax Group & 3 others	74/100
3rd	Aragen 2001, Hyderabad (India), Series B	Provider of drug discovery, clinical development, manufacturing, and other services for small molecules	$161M	Goldman Sachs, Quadria Capital & 18 others	69/100
4th	Syngene 1993, Bengaluru (India), Public	Provider of contract research and manufacturing services for both small molecules and biologics	$85.9M	True North, Education Growth Partners & 9 others	66/100
5th	Abzena 2001, Cambridge (United Kingdom), Acquired	Provider of antibody discovery, cell line development, and bio analytics services	$67.1M	Imperial Innovations, Invesco Perpetual & 11 others	66/100
6th	Abingdon Health 2008, York (United Kingdom), Public	Developer of immunoassays for diagnostic purposes	$24.1M	Imperial Innovations, Mercia & 2 others	64/100
7th	Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired	Aseptic manufacturing CDMO providing fill-finish services for sterile injectables	$16.9M	Municipal Employees' Retirement System, Trout Creek Ventures ... & 5 others	58/100
8th	EirGenix 2012, Taipei (Taiwan), Public	Contract development and manufacturing organization for biologics	-	CDIB Capital Group, Taiwania Capital & 3 others	58/100
9th	Daewoong Pharmaceutical 1945, Seoul (South Korea), Public	Developer of therapies for treating gastrointestinal disorders	-	Business Innovation Network	57/100
10th	Kemwell Biopharma 1980, Bengaluru (India), Acquired	A biologics CDMO providing integrated development and manufacturing	$5.72M	Subhashfamilytrust & 4 others	57/100
48th	Leanbio 2014, Barcelona (Spain), Acquired	Manufacturer of biopharmaceutical product in immunotherapy	$6.28M	Europa	46/100